Medicine
Cancidas 7 mg/mL powder for injection
Cancidas 7 mg/mL powder for injection is a prescription medicine containing Caspofungin for intravenous use, marketed by Merck Sharp & Dohme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
The lyophilized vials should be stored refrigerated at 2° to 8°C (36° to 46°F).
Key facts
- Active ingredient (INN)
- Caspofungin
- Brand
- Cancidas
- Strength
- 7 mg/mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Merck Sharp & Dohme
- Manufacturer
- Merck Sharp & Dohme
- Origin register
- US FDA, United States
- Storage
- The lyophilized vials should be stored refrigerated at 2° to 8°C (36° to 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J02AX04 Caspofungin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 January 2001
- Identifiers
- RxCUI 828539, 828541, 828755 +1DailyMed set ID 3bad23a6-09a6-4194-9182-093ed61bc71cNDC 0006-3823Application NDA021227
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-use in 1 carton / 10.8 mL in 1 vial, single-use | 0006-3823-10 | Merck Sharp & Dohme | 26 January 2001 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Caspofungin 7 mg/mL powder for injection.
Other strengths and forms of Caspofungin
Clinical summary
Caspofungin is an echinocandin antifungal indicated in adults and pediatric patients (3 months of age and older) for empirical therapy for presumed fungal infections in febrile, neutropenic patients, among other approved uses. MedsAcross supplies Caspofungin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CaspofunginFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CANCIDAS prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Cancidas (previously Caspofungin MSD): European public assessment report (EPAR) · European Medicines Agency
Need Cancidas 7 mg/mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.